Preclinical Imaging Evaluation of Novel TSPO-PET Ligand 2-(5,7-Diethyl-2-(4-(2-[18F]fluoroethoxy)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)-N,N-diethylacetamide ([18F]VUIIS1008) in Glioma

被引：0
|
作者：
Dewei Tang
Michael L. Nickels
M. Noor Tantawy
Jason R. Buck
H. Charles Manning
机构：
[1] Vanderbilt University Medical Center,Vanderbilt University Institute of Imaging Science (VUIIS)
[2] Vanderbilt University Medical Center,Department of Radiology and Radiological Sciences
[3] Vanderbilt University Medical Center,Program in Chemical and Physical Biology
[4] Vanderbilt University Medical Center,Vanderbilt
[5] Vanderbilt University,Ingram Cancer Center
[6] Vanderbilt University Medical Center,Department of Biomedical Engineering
[7] Vanderbilt University Medical Center,Department of Neurosurgery
来源：
Molecular Imaging and Biology | 2014年 / 16卷
关键词：
PET; DPA-714; VUIIS1008; TSPO; Glioma; Cancer imaging;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：813 / 820
页数：7
相关论文
共 50 条
  • [41] The nonpeptidyl caspase binding radioligand (S)-1-(4-(2-[18F]fluoroethoxy)benzyl)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin ([18F]CbR) as potential positron emission tomography-compatible apoptosis imaging agent
    Faust, A.
    Wagner, S.
    Law, M. P.
    Hermann, S.
    Schnoeckel, U.
    Keul, P.
    Schober, O.
    Schaefers, M.
    Levkau, B.
    Kopka, K.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 51 (01): : 67 - 73
  • [42] Design, Synthesis, and Evaluation of (4R)-1-{3-[2-(18F)Fluoro-4-methylpyridin-3-yl]phenyl}-4-[4-(1,3-thiazol-2-ylcarbonyl)piperazin-1-yl]pyrrolidin-2-one ([18F]T-401) as a Novel Positron-Emission Tomography Imaging Agent for Monoacylglycerol Lipase
    Hattori, Yasushi
    Aoyama, Kazunobu
    Maeda, Jun
    Arimura, Naoto
    Takahashi, Yasuko
    Sasaki, Masako
    Fujinaga, Masayuki
    Seki, Chie
    Nagai, Yuji
    Kawamura, Kazunori
    Yamasaki, Tomoteru
    Zhang, Ming-Rong
    Higuchi, Makoto
    Koike, Tatsuki
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (05) : 2362 - 2375
  • [43] N-(4-[18F]-fluoropyridin-2-yl)-N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}carboxamides as analogs of WAY100635. New PET tracers of serotonin 5-HT1A receptors
    Garcia, Gonzalo
    Abet, Valentina
    Alajarin, Ramon
    Alvarez-Builla, Julio
    Delgado, Mercedes
    Garcia-Garcia, Luis
    Bascunana-Almarcha, Pablo
    Pena-Salcedo, Carmen
    Kelly, James
    Pozo, Miguel A.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 85 : 795 - 806
  • [44] New PET imaging agent for the serotonin transporter:: [18F]ACF (2-[(2-amino-4-chloro-5-fluorophenyl)thiol-N,N-dimethyl-benzenmethanamine)
    Oya, S
    Choi, SR
    Coenen, H
    Kung, HF
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (21) : 4716 - 4723
  • [45] N-Succinimidyl 3-((4-(4-[18F] fluorobutyl)-1H-1,2,3-triazol-1 yl) methyl)-5-(guanidinomethyl)benzoate ([18F] SFBTMGMB): a residualizing label for 18F-labeling of internalizing biomolecules
    Vaidyanathan, Ganesan
    McDougald, Darryl
    Choi, Jaeyeon
    Pruszynski, Marek
    Koumarianou, Eftychia
    Zhou, Zhengyuan
    Zalutsky, Michael R.
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2016, 14 (04) : 1261 - 1271
  • [46] Discovery of N-{(1S,2S)-2-(3-Cyanophenyl)-3-[4-(2-[18F]fluoroethoxy)phenyl]-1-methylpropyl}-2-methyl-2-[(5-methylpyridin-2-yl)oxy]propanamide, a cannabinoid-1 receptor positron emission tomography tracer suitable for clinical use
    Liu, Ping
    Lin, Linus S.
    Hamill, Terence G.
    Jewell, James P.
    Lanza, Thomas J., Jr.
    Gibson, Raymond E.
    Krause, Stephen M.
    Ryan, Christine
    Eng, Waisi
    Sanabria, Sandra
    Tong, Xinchun
    Wang, Junying
    Levorse, Dorothy A.
    Owens, Karen A.
    Fong, Tung M.
    Shen, Chun-Pyn
    Lao, Julie
    Kumar, Sanjeev
    Yin, Wenji
    Payack, Joseph F.
    Springfield, Shawn A.
    Hargreaves, Richard
    Burns, H. Donald
    Goulet, Mark T.
    Hagmann, William K.
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (15) : 3427 - 3430
  • [47] 18F-labelling of a potent nonpeptide CCR1 antagonist:: synthesis of 1-(5-chloro-2-{2-[(2R)-4-(4-[18F]fluorobenzyl)-2-methylpiperazin-1-yl]-2-oxoethoxy}phenyl)urea in an automated module
    Mäding, P
    Füchtner, F
    Johannsen, B
    Steinbach, J
    Hilger, CS
    Friebe, M
    Halks-Miller, M
    Horuk, R
    Mohan, R
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2006, 49 (03): : 253 - 262
  • [48] Fluorine-18 labeling of a single domain antibody fragment with 2,5-dioxopyrrolidin-1-yl 3-(1-(2-(2-(2-(2-[18F]fluoroethoxy)ethoxy)ethoxy)ethyl)-1H-1,2,3-triazol-4-yl)-5-(guanidinomethyl)benzoate, an alternative residualizing prosthetic agent.
    Zhou, Zhengyuan
    McDougald, Darryl
    Devoogdt, Nick
    Zalutsky, Michael
    Vaidyanathan, Ganesan
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2019, 62 : S484 - S486
  • [49] Crystal structure of methyl 2-(4-(3-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-6-yl)phenyl)acetate, C19H17N5O2
    Fang, Bo
    Meng, Jiang Ping
    Gan, Lin Ling
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2019, 234 (03): : 575 - 577
  • [50] Synthesis and preclinical evaluation of the novel P-gp expression tracer (Z)-2-(4-[18F] fluoro-2-oxoindolin-3-ylidene)-N-(4-methoxyphenyl)hydrazine-carbothioamide.
    Verbeek, Joost
    Eriksson, Jonas
    Syvanen, Stina
    Voskuyl, Rob A.
    Schuit, Robert C.
    Molthoff, Carla F. M.
    de Lange, Elizabeth C.
    Huisman, Marc C.
    Lammertsma, Adriaan A.
    Windhorst, Albert D.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2013, 56 : S341 - S341
12345